XXL Impressions Supplement Memory Claims Impress FTC As False
This article was originally published in The Rose Sheet
Executive Summary
FTC announces agreements to settle complaints against six of nine defendants identified in an investigation of XXL Impressions' advertising for CogniPrin promoted for cognitive benefits and FlexiPrin product promoted to reduce joint paint and rebuild damaged joints and cartilage.
You may also be interested in...
'Free Trial' Offers Cost Marketers Of Supplements With Bogus Claims
FTC sends refunds totaling $60,791 to purchasers of Nobetes' product touted as diabetes treatment and $113,000 for purchases of FlexiPrin, a deceptively marketed joint pain supplement. Commission previously settled with both firms.
FDA Prioritizes Vinpocetine Decison After Animal Study Shows 'Developmental Toxicity'
Agency announces plan in statement by two deputy commissioners warning consumers about safety concerns regarding the semi-synthetic derivative of vincamine, "specifically concerns about the use of this ingredient by women of childbearing age." Recent findings by NIH National Toxicology Program's study with rats and rabbits indicate "vinpocetine may cause a miscarriage or harm fetal development," FDA says.
UAS Labs Expands Probioitic Portfolio: Health And Wellness Industry News
UAS Labs acquires Nebraska Cultures; ingredient supplier guilty in FDA undercover investigation; FTC cuts checks for bogus memory pill refunds; diaper rash cream recall; and kratom recall updates.